17 Feb 2021 07:00
17 February 2021
BIOPHARMA CREDIT PLC
(the "Company")
NOTICE OF FULL YEAR RESULTS
BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor, will announce its audited Full Year Results for the period ending 31 December 2020 on Tuesday 16 March 2021.
A management presentation will be delivered at 2:00pm GMT through a conference call facility. To request conference call details, RSVP to henryw@buchanan.uk.com.
-Ends-
Enquiries
BioPharma Credit PLC
via Link Company Matters Limited
Company Secretary
+44 (0) 1392 477 500
Buchanan
+44 (0)20 7466 5000
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.
LEI: 213800AV55PYXAS7SY24
Biopharma Cred. (BPCR)